1. Home
  2. PRAX vs MUSA Comparison

PRAX vs MUSA Comparison

Compare PRAX & MUSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$312.49

Market Cap

8.8B

Sector

Health Care

ML Signal

HOLD

Logo Murphy USA Inc.

MUSA

Murphy USA Inc.

HOLD

Current Price

$440.28

Market Cap

8.3B

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRAX
MUSA
Founded
2015
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Retail-Auto Dealers and Gas Stations
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
8.8B
8.3B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
PRAX
MUSA
Price
$312.49
$440.28
Analyst Decision
Strong Buy
Buy
Analyst Count
13
6
Target Price
$397.85
$466.80
AVG Volume (30 Days)
616.0K
271.5K
Earning Date
02-27-2026
02-04-2026
Dividend Yield
N/A
0.57%
EPS Growth
N/A
N/A
EPS
N/A
23.64
Revenue
$7,463,000.00
$17,008,099,999.00
Revenue This Year
N/A
$11.19
Revenue Next Year
$14,827.76
$3.15
P/E Ratio
N/A
$18.68
Revenue Growth
364.98
N/A
52 Week Low
$26.70
$345.23
52 Week High
$326.91
$523.09

Technical Indicators

Market Signals
Indicator
PRAX
MUSA
Relative Strength Index (RSI) 66.64 64.32
Support Level $266.93 $412.53
Resistance Level $306.16 $453.57
Average True Range (ATR) 17.82 12.07
MACD -1.32 2.14
Stochastic Oscillator 78.28 75.99

Price Performance

Historical Comparison
PRAX
MUSA

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.

About MUSA Murphy USA Inc.

Murphy USA operates more than 1,700 fueling stations and convenience stores primarily across the Midwest and Southeastern United States. The firm owns about 75% of its locations, with most stores situated in high-traffic areas near Walmart supercenters. Murphy's stores typically range from 1,400-2,800 square feet, with most of its in-store sales derived from tobacco and nicotine products. The company acquired about 150 QuickChek stores in 2021, boosting its presence in grocery and foodservice. Murphy generates about two thirds of its profit from fuel retailing, with the remaining third coming from in-store sales.

Share on Social Networks: